Dolphin AI
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dolphin AI - overview
Established
2024
Location
Jiaxing, Jiangsu, China
Primary Industry
Medical Devices & Equipment
About
Established in 2024 and based in Jiaxing, China, Dolphin AI operates as a medical device developer that focuses on the research and development of AI ultrasound technology equipment. The company's founder, Le Anjie, holds a bachelor's degree in mathematics and a master's degree in data-intensive science from Cambridge University. The company's team comes from universities such as Oxford University, Cambridge University, and Beijing University of Aeronautics and Astronautics, and its members have experience in AI, large models, medical imaging, and other fields. In April 2025, Dolphin AI closed seed funding from new investors ESonic and Jing Capital.
The company uses large-model multimodality and edge computing technology to develop AI ultrasound technology equipment. The company generates revenue by providing AI ultrasound technology equipment.
Current Investors
Jingjing Capital, ESonic
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.